Xiamen Xiangyu (600057.SH): Private placement application approved by China Securities Regulatory Commission.
Xiamen Xiangyu (600057.SH) released an announcement, stating that the company has received approval from the China Securities Regulatory Commission for...
Xiamen Xiangyu (600057.SH) released an announcement stating that the company has received the approval from the China Securities Regulatory Commission to issue shares to specific entities, as outlined in the "Approval for Xiamen Xiangyu Limited Company to Issue Shares to Specific Entities" (CSRC Permit [2025] No.1). The approval allows the company to proceed with its application to issue shares to specific entities.
Related Articles

CONCORD HC GP(02453): Income and profits double, proton therapy drives hospital business explosion

ZHONGMIAO(01471): Rapid growth in performance in 2025, deepening risk management, upgrading ecological construction.

EB SECURITIES: High oil prices drive up the penetration rate of electrification, lithium battery materials are expected to see a simultaneous increase in both quantity and price.
CONCORD HC GP(02453): Income and profits double, proton therapy drives hospital business explosion

ZHONGMIAO(01471): Rapid growth in performance in 2025, deepening risk management, upgrading ecological construction.

EB SECURITIES: High oil prices drive up the penetration rate of electrification, lithium battery materials are expected to see a simultaneous increase in both quantity and price.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


